U.S., March 4 -- ClinicalTrials.gov registry received information related to the study (NCT06854263) titled 'CLARITY Study - PMCF Study' on Feb. 20.

Brief Summary: In the context of the Post-Market Clinical Follow-up (PMCF), this study aimed at evaluating the safety and performance of the RADSAFE(R) inks in the marking of the radiation field.

Study Start Date: April, 2025

Study Type: INTERVENTIONAL

Condition: Radiation Site Marking Prior to Radiation Therapy

Intervention: DEVICE: skin marking for radiotherapy treatment

skin marking for radiotherapy treatment

Recruitment Status: NOT_YET_RECRUITING

Sponsor: Laboratoires BIOTIC Phocea

Published by HT Digital Content Services with permission from Health Daily Digest....